Association of CARD10 rs6000782 and TNF rs1799724 variants with paediatric-onset autoimmune hepatitis
- PMID: 30581618
- PMCID: PMC6300463
- DOI: 10.1016/j.jare.2018.10.001
Association of CARD10 rs6000782 and TNF rs1799724 variants with paediatric-onset autoimmune hepatitis
Abstract
Although the pathogenesis of paediatric-onset autoimmune hepatitis (pAIH) remains incompletely understood, genetic variants and environmental factors are known to be involved. Caspase recruitment domain family member 10 (CARD10) is a scaffold protein that participates in a complex pathway activating nuclear factor kappa-B (NFκB) and tumour necrosis factor alpha (TNF-α). This study aimed to investigate the association of CARD10 rs6000782 (g.37928186A > C) and TNF gene promoter rs1799724 (c.-1037C > T) variants with pAIH susceptibility in a cohort of Egyptian children. The research was also extended to assess the relationship of these variants with levels of NFκB-p65 and TNF-α. Fifty-six pAIH patients and 44 age- and sex-matched healthy controls were included. Variant genotyping was performed by polymerase chain reaction (PCR). Serum NFκB-p65 and TNF-α levels were measured using enzyme-linked immunosorbent assays (ELISAs). rs6000782 C and rs1799724 T alleles, separate or in combination, were significantly increased in pAIH patients compared to controls. Serum levels of NFκB-p65 and TNF-α were higher in pAIH differentiating both groups. Moreover, the recessive model of rs6000782 revealed a significant association with the levels of both NFκB-p65 and TNF-α. In conclusion, rs6000782 and rs1799724 variants are potential genetic risk factors for pAIH predisposition, with the former affecting NFκB-p65 and TNF-α levels. Overall, the inflammatory cascade was associated with the degree of liver cell destruction. Clinically, screening and genetic counselling are recommended for relatives of pAIH patients.
Keywords: Autoimmune; Cytokines; Hepatitis; Paediatrics; Tumour necrosis factor; Variants.
Figures



References
-
- Manns M.P., Lohse A.W., Vergani D. Autoimmune hepatitis – update 2015. J Hepatol. 2015;62(S1):S100–S111. - PubMed
-
- Tang J., Zhou C., Zhang Z.J., Sen Zheng S. Association of polymorphisms in non-classic MHC genes with susceptibility to autoimmune hepatitis. Hepatobiliary Pancreat Dis Int. 2012;11(2):125–131. - PubMed
-
- Lohse A., Chazouilleres O., Daleko G., Drenth J., Heneghan M., Hofer H. EASL clinical practice guidelines: autoimmune hepatitis. J Hepatol. 2015;63(4):971–1004. - PubMed
-
- Van Gerven N.M.F., Verwer B.J., Witte B.I., Van Erpecum K.J., Van Buuren H.R., Maijers I. Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands. Scand J Gastroenterol. 2014;49(10):1245–1254. - PubMed
-
- Delgado J.-S., Vodonos A., Malnick S., Kriger O., Wilkof-Segev R., Delgado B. Autoimmune hepatitis in southern Israel: a 15-year multicenter study. J Dig Dis. 2013;14(11):611–618. - PubMed
LinkOut - more resources
Full Text Sources